Zion Research has published a new report titled “Influenza Market (H1N1 Vaccines and Others) by Product (Influenza Vaccines and Influenza Drugs): Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 – 2020.” According to the report, the global influenza market was valued at USD 4.27 billion in 2014 and it’s expected to reach at USD 6.87 billion by 2020, growing at a CAGR of 8.33% between 2015 and 2020.
To Get Sample Report or Access Report with Complete TOC at http://www.marketresearchstore.com/report/influenza-market-by-product-36077#RequestSample
Influenza infection can affect throat, nose as well as lungs. It’s a contagious disease in which three types of viruses includes namely as influenza type A, influenza type B, influenza type C. Seasonal, pandemic and zoonotic or variant are the types of influenza. Trivalent flu vaccines are made to protect against influenza viruses.
Increasing awareness regarding influenza is one of the major driving factors for global influenza market. Moreover, world health organization (WHO) has also come up with a global action plan for influenza vaccination across the globe. However, influenza market is expected to face major challenge from antigenic drift of influenza viruses. Influenza virus continuously evolves at a rapid pace. Additionally, lack of cold storage facilities presents major challenge for the growth of influenza market.
H1N1 vaccines accounts for major chunk of influenza market with around 79% share of the total market in 2014. Influenza market is also segmented based on drugs and vaccines. Vaccines dominated the influenza market with over 80% share of the market in 2014. It is also expected to be the fastest growing market segment during the forecast period. On the basis of regions, global influenza market has been segmented as Americas, EMEA (Europe, Middle East and Africa) and Asia Pacific. Americas dominated the global market with around 60% share of the global market in 2014. Americas was followed by EMEA and Asia Pacific respectively.
Browse the full “Influenza Market (H1N1 Vaccines and Others) by Product (Influenza Vaccines and Influenza Drugs): Global Industry Perspective, Comprehensive Analysis and Forecast 2014 – 2020” report at http://www.marketresearchstore.com/report/influenza-market-by-product-36077
Some of the key industry participants in global influenza market include AstraZeneca, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis, Sanofi-Pasteur and others. Global influenza market is led by top five companies including AstraZeneca, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis, Sanofi-Pasteur. This five companies accounts for over two third shares of the global market.
This report segments the global influenza market as follows:
Influenza Market – Product Segment Analysis
- Influenza Vaccines
- Influenza Drugs
Influenza Market – Regional Analysis
- EMEA (Europe, Middle East and Africa)
- Asia Pacific
Browse Influenza Market Press Release: http://www.marketresearchstore.com/news/global-influenza-market-is-expected-to-reach-usd-64
Zion Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Zion Research experienced team of Analysts, Researchers, and Consultants uses proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each Zion Research syndicated research report covers a different sector — such as pharmaceuticals, chemical, energy, food and beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports strive to serve the overall research requirement of clients.
3422 SW 15 Street,Suit #8138
Deerfield Beach,Florida 33442
Toll Free: +1-855-465-4651 (USA-CANADA)